Dauntless Investment Group, LLC Inmune Bio, Inc. Transaction History
Dauntless Investment Group, LLC
- $85.4 Billion
- Q1 2025
A detailed history of Dauntless Investment Group, LLC transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Dauntless Investment Group, LLC holds 130,680 shares of INMB stock, worth $347,608. This represents 1.19% of its overall portfolio holdings.
Number of Shares
130,680
Previous 191,822
31.87%
Holding current value
$347,608
Previous $896 Million
13.93%
% of portfolio
1.19%
Previous 0.94%
Shares
2 transactions
Others Institutions Holding INMB
# of Institutions
93Shares Held
6.77MCall Options Held
317KPut Options Held
104K-
Praetorian Pr LLC Rincon, PR865KShares$2.3 Million2.92% of portfolio
-
Vanguard Group Inc Valley Forge, PA827KShares$2.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY813KShares$2.16 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$1.59 Million45.87% of portfolio
-
Geode Capital Management, LLC Boston, MA390KShares$1.04 Million0.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $47.7M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...